Skip to content

Source filing unavailable

Q1 2022 · —
Revenue—
Net Income-$23.84MN/M vs Q1 2021N/M vs Q4 2021
EPS Diluted-$1.58no prior Q1 2021 on fileno prior Q4 2021 on file
Operating Income-$19,898,000—
Operating Cash Flow-$50,793,000—
Free Cash Flowderived-$52,481,000—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ1 2022Q1 2021
Net Income-$23.84M-$86.66M
EPS Diluted-$1.58—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Prime Medicine, Inc. · CIK 1894562 · Engraved from SEC EDGAR